-transparent.png){kind=logo}
Higher plasma concentrations of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT) were obtained after administration of FT (100 mg/kg, i.v.) combined with L-cysteine (CySH, 500 mg/kg, p.o.). The volume of distribution (Vd) and body fluid volumes significantly decreased. These results suggest that the increase of the plasma concentrations of FT can be attributed to the decrease of the Vd of FT, which is considered to be based on the decrease of body fluid volumes by the combined administration of CySH.
Related Publications
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
August 1978,
Journal of medicinal chemistry,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
August 1979,
Cancer research,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
January 1979,
Nucleic acids symposium series,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
January 1981,
Cancer chemotherapy and pharmacology,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
January 1981,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
September 1984,
Japanese journal of pharmacology,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
November 1978,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
November 1978,
Cancer research,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
February 1987,
Gastroenterologia Japonica,
N Kawabata, and
K Yano, and
H Ohno, and
T Nakashima
May 1981,
Chemical & pharmaceutical bulletin,
